EMA Welcomes Political Agreement on Critical Medicines Act
The European Medicines Agency (EMA) has welcomed the political agreement reached on the Critical Medicines Act. This act aims to ensure a stable supply of essential medicines across the EU, addressing shortages and strengthening the resilience of the European pharmaceutical market. This development is crucial for patient safety and public health, guaranteeing access to vital treatments. It signifies a significant step towards a more robust and secure medicines supply chain in Europe.
New EU act promises more secure and stable supply of critical medicines.